Catalyst Wire Dossier Catalyst Wire Dossier

Pegcetacoplan

Pegcetacoplan · Apellis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Pegcetacoplan, covering 2020-09-16 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Pegcetacoplan Long Term Safety and Efficacy Extension Study [Phase 3]

See pricing